1. Local estrogen for vaginal atrophy in postmenopausal women;Suckling;Cochrane Database of Systematic Reviews,2006
2. Urogenital symptoms and resulting discomfort in non-institutionalized Dutch women aged 50–75 years;van Geelen;International Urogynecology Journal,2000
3. The role of local vaginal estrogen for treatment of vaginal atrophy in post menopausal women: 2007 position statement of the North American Menopause Society;The North American Menopause Society;Menopause,2007
4. Vaginal pH as a marker for bacterial pathogens and menopausal status;Caillouette;American Journal of Obstetrics and Gynecology,1997
5. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for industry, estrogen and estrogen/progestin drug products to treat vasomotor symproms and vulvar and vaginal atrophy symptoms—recommendations for clinical evaluation. ; 2003, January.